Less is more.
The CBO report outlining its 2013-2023 projections is not pretty reading -- but there is one exception:
“The largest downward revision in the current baseline is for spending for Medicare’s Part D.” (This citation appears on page 57 of the report.)
The actual data table can be found here.
The ever-accumulating evidence shows that Part D is succeeding beyond all expectations, delivering needed prescription drugs to Medicare beneficiaries for less money than anyone expected—driven by strong competition among plans.
Note to President Obama, if it ain’t broke, don’t fix it.
Smart partnership between government and the free market works.
